Vernalis is a pharmaceutical firm that develops and commercializes therapeutics for the treatment of cancer and nervous system disorders.
Business Model:
Revenue: $11.4M
Employees: 51-200
Vernalis, PLC was acquired by
HitGen.
The acquisition happend on 2020-10-12.
Details of the transaction were not public
Address: Granta Park
City: Cambridge
State: england
Zip: CB21 6GB
Country: GB
Vernalis is a pharmaceutical firm that develops and commercializes therapeutics for the treatment of cancer and nervous system disorders.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
Ticker Symbol:
VER
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2007 | Venture Round | 1 | - |
Thuja Capital Thuja Capital Thuja Capital Thuja Capital |
1/2007 | Venture Round | 1 | - |
Thuja Capital Thuja Capital Thuja Capital Thuja Capital |
---|
Announced Date | Name | Price |
---|---|---|
11/2005 | Cita NeuroPharmaceuticals Inc. | |
7/2005 | Ionix Pharmaceuticals | |
4/2005 | Pintex Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|